It is also hypothesized that with aging there may be a requirement for higher levels of VWF for optimal hemostasis; thus, amelioration of bleeding symptoms may not be observed in aging VWD patients [89]. This evidence concerns the gene VWF and von Willebrand disease (hereditary or acquired).